Antioxidant systems in polymorphonuclear leucocytes of Type 2 diabetes mellitus

Diabetic Medicine

Volumn 16, Issue 1, 1999, Pages 74-78

  Muchova J ^a   Liptakova A ^a   Orszaghova Z ^a   Garaiova I ^a   Tison P ^b   Carsky J ^a   Ďuračková, Zdena ^a,b  

^a Dept of Med Chem Biochem/C   (Slovakia)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

Author keywords

Antioxidant systems; PMN leucocytes; Thiobarbituric acid reactive products; Type 2 diabetes mellitus

Indexed keywords

CATALASE; FRUCTOSAMINE; GLUCOSE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLYCOSYLATED HEMOGLOBIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME MECHANISM; GLYCATION; HUMAN; LIPID PEROXIDATION; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS;

ADULT; ANTIOXIDANTS; CATALASE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NEUTROPHILS; SUPEROXIDE DISMUTASE;

EID: 0033013268     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00015.x     Document Type: Article

References (26)

1. 1 Wolff SP. The potential role of oxidative stress in the diabetic complications: novel implications for theory and therapy. Diabetic Complications Scientific and Clinical Aspects. Edinburgh: Churchill Livingstone, 1987: 167-220.
2. 2 Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.
3. 3 Nolan ChM, Beaty HN, Bagdade JD. Further characterization of the impaired bactericidal function of granulocytes in patient with poorly controlled diabetes. Diabetes 1978; 27: 889-894.
4. 4 Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias Ch, Smith H. Infection and diabetes: the case of glucose control. Am J Med 1982; 72: 439-450.
5. 5 Carella M, Gossain V, Rovner D. Early diabetic nephropathy. Arch Intern Med 1994; 154: 625-630.
6. 6 Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; Suppl 21: 77-89.
7. 7 Lowry OH, Rosebrough NJ, Farr AJ, Randall RJ. Protein measurement with folin-phenol reagent. J Biol Chem 1951; 193: 265-275.
8. 8 McCord JM, Fridovich I. Superoxide dismutase. Enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 224: 6049-6055.
9. 9 Blanchflower WJ, Rice DA, Davidson WB. Blood glutathione peroxidase. A method for measurement and the influence of storage, cyanide, and Drabkin's reagent on enzyme activity. Biol Trace Elem Res 1986; 11: 89-100.
10. 10 Delides A, Spooner RJ, Goldberg DM, Neal FE. An optimized semi-automatic rate method for serum glutathione reductase activity and its application to patients with malignant disease. J Clin Path 1976; 29: 73-77.
11. 11 Cavarocchi NC, England MD, O'Brien JF, Solis E, Russo P, Schaff HV et al. Superoxide Generation during Cardiopulmonary Bypass: Is There a Role for Vitamin E? J Surg Res 1986; 40: 519-527.
12. 12 Wong SHY, Knight JA, Hopfer IM, Zaharia O, Leach ChU, Jr, Sunderman FW, Jr. Lipoperoxides in plasma as measured by liquid-chromatographic saparation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987; 33: 214-220.
13. 1C. FEBS Lett 1976; 71: 356-360.
14. 14 Arai K, Maguchi S, Fujii S, Ishibashi H, Oikawa K, Taniguchi N. Glycation and Inactivation of human Cu-Zn-superoxide dismutase. J Biol Chem 1987; 262: 16969-16972.
15. 15 Wolff SP, Dean RT. Glucose autooxidation and protein oxidation: the role of autooxidative glycosylation in diabetes mellitus and ageing. Biochem J 1987; 245: 243-250.
16. .-). production by polymorphonuclear neutrophils from patients with diabetes mellitus. Folia Haematol 1985; 112: 658-668.
17. 17 Delamaire M, Maugendre D, Moreno M, Le Goff M-C, Allannic H, Genetet B. Impared leukocyte function in diabetic patients. Diabetic Med 1997; 14: 29-34.
18. 18 Stocker R, Frei B. Endogenous antioxidant defence in human blood plasma. In Sies H, eds. Oxidative Stress: Oxidants and Antioxidants. Dusseldorf: Academic Press, 1991, 213-245.
19. 19 Chari SN, Nath N, Rathi AB. Glutathione and its redox system in diabetic polymorphonuclear leukocytes. Am J Med Sci 1984; 287: 14-15.
20. 20 Wohaieb SA, Godin V. Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 1987; 36: 1014-1018.
21. 21 Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, Nguyen AT, Thévenin M, Jaudon MCh et al. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Rad Biol Med 1996; 21: 845-853.
22. 22 Gallou G, Ruelland A, Legras B, Maugendre D, Allannic H, Cloarec L. Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin Chim Acta 1993; 214: 227-234.
23. 23 Kaji H, Kurasaki M, Ito K, Saito T, Saito K, Niioka T et al. Increased lipoperoxide value and glutathione peroxidase activity in blood plasma in type 2 (non-insulin-dependent) diabetic women. Klin Wochencchr 1985; 63: 765-768.
24. 24 Noberasco G, Odetti P, Boeri D, Maiello M, Adezati L. Malondialdehyde (MDA) level in diabetic subjects. Relationship with blood glucose and glycosylated hemoglobin. Biomed Pharmacother 1991; 45: 193-196.
25. 25 Vijayalingam S, Parthiban A, Shanmugasundaram KR, Mohan V. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetic Med 1996; 13: 715-719.
26. 26 Richard MJ, Portal B, Moe J, Coudray C. Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin Chem 1992; 38: 704-709.